期刊
EMERGING INFECTIOUS DISEASES
卷 10, 期 2, 页码 317-319出版社
CENTERS DISEASE CONTROL
DOI: 10.3201/eid1002.030482
关键词
-
资金
- NIAID NIH HHS [R21 AI053539] Funding Source: Medline
A global outbreak of severe acute respiratory syndrome (SARS) caused by a novel coronavirus began in March 2003. The rapid emergence of SARS and the substantial illness and death it caused have made it a critical public health issue. Because no effective treatments are available, an intensive effort is under way to identify and test promising antiviral drugs. Here, we report that recombinant human interferon -beta la potently inhibits SARS coronavirus replication in vitro.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据